FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1868732893> ?p ?o ?g. }

• W1868732893 endingPage "26" @default.
• W1868732893 startingPage "1" @default.
• W1868732893 abstract "Immunoglobulin A nephropathy: Clinical Practice Guidelines. Immunoglobulin A nephropathy (N.IgA) is the world most common glomerular disease; 15-50% of patients develop loss of renal function in 10-20 years, and the rest remission or mild proteinuria/ hematuria. The optimal treatment is uncertain. Our aim was to develop evidence-based recommendations through research in Medline, Embasse, Lilacs and Cochrane Central Register of Controlled Trials. The study-quality was independently assessed by the reviewers following the Cochrane Renal Group checklist: randomization, blinding, intention-to-treat analysis and follow-up period. Levels of evidence and grades of recommendation were assigned according to Center for Evidence-Based Medicine, Oxford. Two approaches were considered: Immunosuppressive therapy (corticosteroids, cytostatics, cyclosporine A, mycophenolate-mofetil): Level I a, grade A. –Combined suppressive therapy in adults. Corticosteroids plus cytotoxics drugs (cyclophosphamide/azathioprine): Level II b, grade B. In children with severe IgA nephropathy: Level II b, grade D. Cyclosporine and mycophenolatemophetil: Level II b, grade C. Cyclosporine and mycophenolate-mophetil: Level ll b, grade C. –Non immunosuppressive therapy: reninangiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers (ARB), fish oil, statins, antiplatelets and tonsillectomy. ACEI and/or ARB, in patients with proteinuria ≥1 g: Level I a, grade A. In children with moderate proteinuria: ACEI and/or ARB with close monitoring of renal function and serum potassium level: Level II b, grade B. Antiplatelet as supportive treatment: Level I a, grade C. Fish oil in addition to ACEI or ARB in patients with mild histological lesions: Level II b, grade B (Not in children). Statins: no evidence to recommend these drugs in children. In patients > 5 years with nephrotic syndrome and hyper-cholesterolemia, use statins with close monitoring of serum creatine-kinase. There is no evidence to recommend tonsillectomy." @default.
• W1868732893 created "2016-06-24" @default.
• W1868732893 creator A5051011103 @default.
• W1868732893 creator A5056416476 @default.
• W1868732893 creator A5071424816 @default.
• W1868732893 creator A5075435520 @default.
• W1868732893 creator A5088881620 @default.
• W1868732893 date "2011-05-01" @default.
• W1868732893 modified "2023-10-17" @default.
• W1868732893 title "Nefropatía por Inmunoglobulina A: Guía de práctica clínica" @default.
• W1868732893 cites W125804383 @default.
• W1868732893 cites W1275674295 @default.
• W1868732893 cites W133099002 @default.
• W1868732893 cites W1418015139 @default.
• W1868732893 cites W1971835203 @default.
• W1868732893 cites W1974752290 @default.
• W1868732893 cites W1976236607 @default.
• W1868732893 cites W1978029528 @default.
• W1868732893 cites W1978607455 @default.
• W1868732893 cites W1982085852 @default.
• W1868732893 cites W1983861492 @default.
• W1868732893 cites W1985040324 @default.
• W1868732893 cites W1987519860 @default.
• W1868732893 cites W1990320213 @default.
• W1868732893 cites W2000581122 @default.
• W1868732893 cites W2001045877 @default.
• W1868732893 cites W2002051261 @default.
• W1868732893 cites W2010602089 @default.
• W1868732893 cites W2011665041 @default.
• W1868732893 cites W2015333250 @default.
• W1868732893 cites W2019639026 @default.
• W1868732893 cites W2022846000 @default.
• W1868732893 cites W2033180759 @default.
• W1868732893 cites W2033673225 @default.
• W1868732893 cites W2034580483 @default.
• W1868732893 cites W2041699718 @default.
• W1868732893 cites W2046529630 @default.
• W1868732893 cites W2048522842 @default.
• W1868732893 cites W2052729937 @default.
• W1868732893 cites W2054418276 @default.
• W1868732893 cites W2059253022 @default.
• W1868732893 cites W2060993823 @default.
• W1868732893 cites W2061904336 @default.
• W1868732893 cites W2063159746 @default.
• W1868732893 cites W2068758108 @default.
• W1868732893 cites W2069708481 @default.
• W1868732893 cites W2085126429 @default.
• W1868732893 cites W2088166619 @default.
• W1868732893 cites W2088745874 @default.
• W1868732893 cites W2089876742 @default.
• W1868732893 cites W2094005904 @default.
• W1868732893 cites W2096190752 @default.
• W1868732893 cites W2105803357 @default.
• W1868732893 cites W2107050894 @default.
• W1868732893 cites W2107793847 @default.
• W1868732893 cites W2108829447 @default.
• W1868732893 cites W2116730178 @default.
• W1868732893 cites W2119111019 @default.
• W1868732893 cites W2120547009 @default.
• W1868732893 cites W2123048854 @default.
• W1868732893 cites W2125084234 @default.
• W1868732893 cites W2125136564 @default.
• W1868732893 cites W2125785855 @default.
• W1868732893 cites W2129128740 @default.
• W1868732893 cites W2143144750 @default.
• W1868732893 cites W2151047279 @default.
• W1868732893 cites W2153340936 @default.
• W1868732893 cites W2156213962 @default.
• W1868732893 cites W2164059447 @default.
• W1868732893 cites W2164289320 @default.
• W1868732893 cites W2168065965 @default.
• W1868732893 cites W2169111359 @default.
• W1868732893 cites W2170268607 @default.
• W1868732893 cites W2257438886 @default.
• W1868732893 cites W2260388166 @default.
• W1868732893 cites W2262508674 @default.
• W1868732893 cites W2321910386 @default.
• W1868732893 cites W2341052589 @default.
• W1868732893 cites W2345529911 @default.
• W1868732893 cites W2354455325 @default.
• W1868732893 cites W2606651900 @default.
• W1868732893 cites W2041781062 @default.
• W1868732893 hasPublicationYear "2011" @default.
• W1868732893 type Work @default.
• W1868732893 sameAs 1868732893 @default.
• W1868732893 citedByCount "0" @default.
• W1868732893 crossrefType "journal-article" @default.
• W1868732893 hasAuthorship W1868732893A5051011103 @default.
• W1868732893 hasAuthorship W1868732893A5056416476 @default.
• W1868732893 hasAuthorship W1868732893A5071424816 @default.
• W1868732893 hasAuthorship W1868732893A5075435520 @default.
• W1868732893 hasAuthorship W1868732893A5088881620 @default.
• W1868732893 hasConcept C126322002 @default.
• W1868732893 hasConcept C134018914 @default.
• W1868732893 hasConcept C159641895 @default.
• W1868732893 hasConcept C2776760755 @default.
• W1868732893 hasConcept C2779134260 @default.
• W1868732893 hasConcept C2779561371 @default.

• next